NCT01547533

Brief Summary

The investigators propose to study the transfer of benznidazole into breastmilk from the blood of lactating women who receive the drug for the treatment of Chagas disease. Breastmilk and blood samples will be obtained from these patients at given times after they take the clinically indicated medication, and the concentrations in both matrices will be compared to estimate degree of transfer, which in turn will be used to evaluate potential degree of exposure of infants breastfed by these women. This study will help clarify safety of continuing breastfeeding while receiving treatment with benznidazole for Chagas disease.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2011

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2011

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

March 1, 2012

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 8, 2012

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2013

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2013

Completed
Last Updated

March 18, 2015

Status Verified

March 1, 2015

Enrollment Period

1.8 years

First QC Date

March 1, 2012

Last Update Submit

March 17, 2015

Conditions

Keywords

Chagas diseaselactationbreastmilkpostpartum periodinfantspediatric clinical pharmacologydevelopmental clinical pharmacologyparasitologytrypanosoma cruzi

Outcome Measures

Primary Outcomes (1)

  • Benznidazole concentration in breastmilk and in plasma

    Randomly obtained breastmilk samples will be obtained to both evaluate the breastmilk / plasma concentration ratio of the drug, and to develop a population pharmacokinetics model of drug trasfer into breastmilk, if possible. Breastmilk concentrations will be used to calculate potential infant exposure through breastmilk to the medication (benznidazole) taken by the mother

    at randomly selected time points during the 30 days of treatment

Secondary Outcomes (1)

  • incidence of adverse drug reactions in women treated with benznidazole during lactation

    throughout the 30 days of treatment

Study Arms (1)

Lactating Women with Chagas disease

Women with Chagas disease who fulfill clinical criteria for treatment with benznidazole, and who are also lactating

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

population of young women with Chagas disease referred to our center for evaluation and treatment

You may qualify if:

  • Lactating women with Chagas disease, not treated before
  • Use of contraception

You may not qualify if:

  • History of allergy to benznidazole or its excipients
  • Pregnancy
  • Significant heart involvement (due to Chagas disease)
  • Significant systemic diseases that could affect the interpretation of the results in the opinion of the principal investigator

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Parasitology and Chagas Service, Buenos Aires Children´s Hospital Ricardo Gutierrez

Buenos Aires, Buenos Aires, 1425, Argentina

Location

Related Publications (1)

  • Garcia-Bournissen F, Moroni S, Marson ME, Moscatelli G, Mastrantonio G, Bisio M, Cornou L, Ballering G, Altcheh J. Limited infant exposure to benznidazole through breast milk during maternal treatment for Chagas disease. Arch Dis Child. 2015 Jan;100(1):90-4. doi: 10.1136/archdischild-2014-306358. Epub 2014 Sep 10.

Biospecimen

Retention: SAMPLES WITHOUT DNA

breastmilk; plasma

MeSH Terms

Conditions

Chagas DiseaseBreast Feeding

Condition Hierarchy (Ancestors)

TrypanosomiasisEuglenozoa InfectionsProtozoan InfectionsParasitic DiseasesInfectionsVector Borne DiseasesFeeding BehaviorBehavior

Study Officials

  • Facundo Garcia Bournissen, MD PhD

    Buenos Aires Children´s Hospital Ricardo Gutierrez ; CONICET

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Researcher

Study Record Dates

First Submitted

March 1, 2012

First Posted

March 8, 2012

Study Start

August 1, 2011

Primary Completion

June 1, 2013

Study Completion

December 1, 2013

Last Updated

March 18, 2015

Record last verified: 2015-03

Locations